Insulin-derived amyloidosis
CMAJ
.
2022 Dec 5;194(47):E1616.
doi: 10.1503/cmaj.220531.
Author
Yasuhiro Kano
1
Affiliation
1
Department of General Internal Medicine, Tokyo Metropolitan Tama Medical Center, Tokyo, Japan yasuhiro.kano.21@gmail.com.
PMID:
36507789
PMCID:
PMC9828975
DOI:
10.1503/cmaj.220531
No abstract available
MeSH terms
Amyloidosis* / diagnosis
Humans
Hypoglycemic Agents
Insulin* / therapeutic use
Substances
Insulin
Hypoglycemic Agents